Clinical and Immunologic Effects of Paraprobiotics in Long-COVID Patients: A Pilot Study.

María José DocampoMattei BatruchPietro OldratiErnesto Berenjeno-CorreaMarc HiltyGabriel LeventhalAndreas LutterottiRoland MartinMireia Sospedra

Published in: Neurology(R) neuroimmunology & neuroinflammation (2024)

This study provides Class IV evidence that paraprobiotics increase the probability of favorable changes of clinical and immunologic markers in patients with long-COVID.

Keyphrases

sars cov
coronavirus disease